The equity shares of Laurus Labs listed at a premium over their issue price under the IPO.
The counter opened at Rs.489.90 on NSE, up around 14 percent over the issue price. On the BSE, the stock opened at Rs.490 and touched an intraday high of Rs.498
Stay tuned to Indian IPO Blog for Laurus Labs IPO Listing day summary
The equity shares of Laurus Labs are likely to be listed on the exchanges effective from Mon, Dec 19, 2016. The shares would be listed on both BSE and NSE
The allotment of shares under the IPO was declared on Dec 15. Laurus Labs is in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.
IPO was subscribed 4.5 times on an overall basis with close to around 1.5 times subscription in the Retail category
